Erratum: Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study (Leukemia (2012) 26 (149-157) DOI: 10.1038/leu.2011.196)

S. K. Kumar; J. H. Lee; J. J. Lahuerta; G. Morgan; P. G. Richardson; J. Crowley; J. Haessler; J. Feather; A. Hoering; P. Moreau; X. Leleu; C. Hulin; S. K. Klein; P. Sonneveld; D. Siegel; J. Bladeé; H. Goldschmidt; S. Jagannath; J. S. Miguel; R. Orlowski; A. Palumbo; O. Sezer; S. V. Rajkumar

doi:10.1038/leu.2012.15

Erratum: Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study (Leukemia (2012) 26 (149-157) DOI: 10.1038/leu.2011.196)

S. K. Kumar
, J. H. Lee
, J. J. Lahuerta
, G. Morgan
, P. G. Richardson
, J. Crowley
, J. Haessler
, J. Feather
, A. Hoering
, P. Moreau
, X. Leleu
, C. Hulin
, S. K. Klein
, P. Sonneveld
, D. Siegel
, J. Bladeé
, H. Goldschmidt
, S. Jagannath
, J. S. Miguel
, R. Orlowski

A. Palumbo, O. Sezer, S. V. Rajkumar

School of Medicine

Research output: Contribution to journal › Comment/debate

6 Scopus citations

Original language	English
Pages (from-to)	1153
Number of pages	1
Journal	Leukemia
Volume	26
Issue number	5
DOIs	https://doi.org/10.1038/leu.2012.15
State	Published - May 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1038/leu.2012.15

Cite this

Kumar, S. K., Lee, J. H., Lahuerta, J. J., Morgan, G., Richardson, P. G., Crowley, J., Haessler, J., Feather, J., Hoering, A., Moreau, P., Leleu, X., Hulin, C., Klein, S. K., Sonneveld, P., Siegel, D., Bladeé, J., Goldschmidt, H., Jagannath, S., Miguel, J. S., ... Rajkumar, S. V. (2012). Erratum: Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study (Leukemia (2012) 26 (149-157) DOI: 10.1038/leu.2011.196). Leukemia, 26(5), 1153. https://doi.org/10.1038/leu.2012.15

@article{ca0395a0de2149fc88ce4ffc3e375760,

title = "Erratum: Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study (Leukemia (2012) 26 (149-157) DOI: 10.1038/leu.2011.196)",

author = "Kumar, \{S. K.\} and Lee, \{J. H.\} and Lahuerta, \{J. J.\} and G. Morgan and Richardson, \{P. G.\} and J. Crowley and J. Haessler and J. Feather and A. Hoering and P. Moreau and X. Leleu and C. Hulin and Klein, \{S. K.\} and P. Sonneveld and D. Siegel and J. Blade{\'e} and H. Goldschmidt and S. Jagannath and Miguel, \{J. S.\} and R. Orlowski and A. Palumbo and O. Sezer and Rajkumar, \{S. V.\}",

year = "2012",

month = may,

doi = "10.1038/leu.2012.15",

language = "English",

volume = "26",

pages = "1153",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "5",

}

Kumar, SK, Lee, JH, Lahuerta, JJ, Morgan, G, Richardson, PG, Crowley, J, Haessler, J, Feather, J, Hoering, A, Moreau, P, Leleu, X, Hulin, C, Klein, SK, Sonneveld, P, Siegel, D, Bladeé, J, Goldschmidt, H, Jagannath, S, Miguel, JS, Orlowski, R, Palumbo, A, Sezer, O & Rajkumar, SV 2012, 'Erratum: Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study (Leukemia (2012) 26 (149-157) DOI: 10.1038/leu.2011.196)', Leukemia, vol. 26, no. 5, pp. 1153. https://doi.org/10.1038/leu.2012.15

Erratum: Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study (Leukemia (2012) 26 (149-157) DOI: 10.1038/leu.2011.196). / Kumar, S. K.; Lee, J. H.; Lahuerta, J. J. et al.
In: Leukemia, Vol. 26, No. 5, 05.2012, p. 1153.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum

T2 - Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study (Leukemia (2012) 26 (149-157) DOI: 10.1038/leu.2011.196)

AU - Kumar, S. K.

AU - Lee, J. H.

AU - Lahuerta, J. J.

AU - Morgan, G.

AU - Richardson, P. G.

AU - Crowley, J.

AU - Haessler, J.

AU - Feather, J.

AU - Hoering, A.

AU - Moreau, P.

AU - Leleu, X.

AU - Hulin, C.

AU - Klein, S. K.

AU - Sonneveld, P.

AU - Siegel, D.

AU - Bladeé, J.

AU - Goldschmidt, H.

AU - Jagannath, S.

AU - Miguel, J. S.

AU - Orlowski, R.

AU - Palumbo, A.

AU - Sezer, O.

AU - Rajkumar, S. V.

PY - 2012/5

Y1 - 2012/5

UR - https://www.scopus.com/pages/publications/84860711612

U2 - 10.1038/leu.2012.15

DO - 10.1038/leu.2012.15

M3 - Comment/debate

AN - SCOPUS:84860711612

SN - 0887-6924

VL - 26

SP - 1153

JO - Leukemia

JF - Leukemia

IS - 5

ER -

Erratum: Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study (Leukemia (2012) 26 (149-157) DOI: 10.1038/leu.2011.196)

UN SDGs

Access to Document

Other files and links

Cite this